Get access to our best features

Get access to our best features

Published 2 years ago

Psygen Receives Dealer's Licence from Health Canada

Summary by Ground News

Psygen Industries Ltd. (together with its subsidiaries, "Psygen") is pleased to announce that its wholly-owned subsidiary, Psygen Labs Inc., received a dealer's licence issued by Health Canada on January 17, 2022 (the "Dealer's Licence") Psygen will begin onsite manufacturing of synthetic psychedelics in accordance with Good Manufacturing Practices ("GMP") for use in clinical and scientific research. Psygen is positioned to be a leader in manufacturing and sale of synthetic psychedelic APIs.

0 Articles

0 Articles

All

Left

Center

Right

Psygen Receives Dealer's Licence from Health Canada

Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Psygen Industries Ltd. (together with its subsidiaries, 'Psygen') is pleased to

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.